TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3/14/24 21:00 | 3/12/24 | CPNG | Coupang, Inc. | DE | Retail | eCom | Catalog & Mail-Order Houses | Svf Investments (Uk) Ltd | X0 | T | S.m | -894,927 | 19.20 | 0 | -46,614 | -12 | 349,542 | I | |||||||||||||||
12/1/23 21:00 | 11/29/23 | CPNG | Coupang, Inc. | DE | Retail | eCom | Catalog & Mail-Order Houses | Svf Investments (Uk) Ltd | X0 | T | S | -461,700 | 15.39 | 0 | -30,000 | -7 | 396,156 | I | |||||||||||||||
10/2/23 21:00 | 9/28/23 | ROIV | Roivant Sciences Ltd. | D0 | Health | Drug | Pharmaceutical Preparations | Svf Investments (Uk) Ltd | X0 | T | S | -126,000 | 12.60 | 0 | -10,000 | -12 | 73,032 | I | |||||||||||||||
3/22/23 21:00 | 3/20/23 | ROIV | Roivant Sciences Ltd. | D0 | Health | Drug | Pharmaceutical Preparations | Svf Investments (Uk) Ltd | X0 | T | S | -96,000 | 8.00 | 0 | -12,000 | -13 | 83,032 | I | |||||||||||||||
12/7/22 21:30 | 12/5/22 | CPNG | Coupang, Inc. | DE | Retail | eCom | Catalog & Mail-Order Houses | Svf Investments (Uk) Ltd | X0 | T | S | -647,500 | 18.50 | 0 | -35,000 | -8 | 426,156 | I | |||||||||||||||
11/15/22 21:00 | 11/10/22 | ROIV | Roivant Sciences Ltd. | D0 | Health | Drug | Pharmaceutical Preparations | Svf Investments (Uk) Ltd | X0 | T | S | -20,634 | 4.75 | 0 | -4,344 | -4 | 95,032 | I |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |